内皮细胞表达MYH9-RD E1841K突变体导致VWF分泌缺陷并破坏止血
本研究探讨内皮细胞表达MYH9突变体在MYH9相关疾病出血症状中的作用。在内皮细胞中表达5种最常见NMII-A突变体,发现E1841K突变体内皮细胞对cAMP信号激动剂的VWF分泌少于对照。构建内皮细胞特异性Myh9 E1841K敲入小鼠和巨核细胞特异性敲入小鼠,前者表现为cAMP诱导的VWF释放受损和出血时间延长而血小板正常,后者表现为巨血小板减少和出血时间延长而VWF释放正常。机制上E1841K突变干扰S1943磷酸化和Rab27a阳性WPBs周边分布,并干扰S1916磷酸化、减少WPBs周围肌动蛋白骨架形成和VWF分泌。结果提示E1841K突变所致内皮细胞cAMP诱导的VWF分泌受损可能参与MYH9-RD出血表型。
要点
- 内皮细胞表达E1841K突变体对cAMP激动剂的VWF分泌少于对照。
- 内皮特异性E1841K敲入小鼠VWF释放受损、出血时间延长而血小板正常。
- 巨核细胞特异性E1841K敲入小鼠巨血小板减少、出血时间延长而VWF释放正常。
核心结论
- E1841K突变体表达所致内皮细胞cAMP诱导的VWF分泌受损可能参与MYH9-RD出血表型。
研究设计与样本
- 在内皮细胞中表达5种最常见的NMII-A突变体,比较VWF分泌。
- 构建2种敲入小鼠品系,一种在内皮细胞表达Myh9 E1841K,另一种在巨核细胞表达Myh9 E1841K。
主要发现
- 表达E1841K突变体的内皮细胞对cAMP信号激动剂的VWF分泌少于对照。
- 内皮特异性E1841K小鼠cAMP诱导的VWF释放受损,出血时间延长,血小板正常。
- 巨核细胞特异性E1841K小鼠表现巨血小板减少,出血时间延长,VWF释放正常。
- 静息条件下E1841K突变干扰S1943磷酸化并损害Rab27a阳性WPBs的周边分布。
- cAMP激动剂刺激下E1841K突变通过破坏与zyxin和CKIIα的相互作用干扰S1916磷酸化,减少WPBs周围肌动蛋白骨架形成及后续VWF分泌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mutations in MYH9, the gene encoding the heavy chain of nonmuscle myosin IIa (NMII-A), cause MYH9-related disease (MYH9-RD), which is an autosomal-dominant thrombocytopenia with bleeding tendency. Previously, we showed that NMII-A in endothelial cells (ECs) is critical for hemostasis via regulating von Willebrand factor (VWF) release from Weibel-Palade bodies (WPBs). The aim of this study was to determine the role of the expression of MYH9 mutants in ECs in the pathogenesis of the MYH9-RD bleeding symptom. First, we expressed the 5 most common NMII-A mutants in ECs and found that E1841K mutant-expressing ECs secreted less VWF than the controls in response to a cyclic adenosine monophosphate (cAMP) signaling agonist. Then, we generated 2 knockin mouse lines, 1 with Myh9 E1841K in ECs and the other in megakaryocytes. Endothelium-specific E1841K mice exhibited impaired cAMP-induced VWF release and a prolonged bleeding time with normal platelets, whereas megakaryocyte-specific E1841K mice exhibited macrothrombocytopenia and a prolonged bleeding time with normal VWF release. Finally, we presented mechanistic findings that E1841K mutation not only interferes with S1943 phosphorylation and impairs the peripheral distribution of Rab27a-positive WPBs in Ecs under quiescent condition but also interferes with S1916 phosphorylation by disrupting the interaction with zyxin and CKIIα and reduces actin framework formation around WPBs and subsequent VWF secretion under the stimulation by a cAMP agonist. Altogether, our results suggest that impaired cAMP-induced endothelial VWF secretion by E1841K mutant expression may contribute to the MYH9-RD bleeding phenotype.
引用
- Cao Y, Sun Y, Deng Y, et al. Defective VWF secretion due to expression of MYH9-RD E1841K mutant in endothelial cells disrupts hemostasis. Blood Adv. 2022. PMID: 35764499. doi:10.1182/bloodadvances.2022008011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。